Head of Research & Technology · SANGAMO THERAPEUTICS, INC · Common Stock
Side
SELL
Value
$18K
Shares
69.8K
Price
$0.25
Executed
Apr 22, 2026
Disclosed
Apr 23, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Apr 22 executedApr 23, 2026 disclosed
SGMO · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Davis Gregory D filed this Form 4 reporting a open-market sale of SGMO on Apr 22, 2026. It became public on Apr 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Head of Research & Technology
Davis Gregory Dcik:0002041855
Issuer
SANGAMO THERAPEUTICS, INCcik:0001001233
Revision history · 0
No field has changed since this record was first ingested.
Company events
No records
No material filings recorded for this issuer.
Source error
Price history for SGMO is unavailable.
An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.
